Cargando…
Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein
COVID-19 is an emerging disease that poses a severe threat to global public health. As such, there is an urgent demand for vaccines against SARS-CoV-2, the virus that causes COVID-19. Here, we describe a virus-like nanoparticle candidate vaccine against SARS-CoV-2 produced by an E. coli expression s...
Autores principales: | Zhou, Yong-Fei, Nie, Jiao-Jiao, Shi, Chao, Ning, Ke, Cao, Yu-Feng, Xie, Yanbo, Xiang, Hongyu, Xie, Qiuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Microbiology and Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668089/ https://www.ncbi.nlm.nih.gov/pubmed/36224764 http://dx.doi.org/10.4014/jmb.2205.05023 |
Ejemplares similares
-
The Capsid (ORF2) Protein of Hepatitis E Virus in Feces Is C-Terminally Truncated
por: Nishiyama, Takashi, et al.
Publicado: (2021) -
Antigenic Characterization of ORF2 and ORF3 Proteins of Hepatitis E Virus (HEV)
por: Pezzoni, Giulia, et al.
Publicado: (2021) -
Detection of Serum Antibodies to Hepatitis E Virus Based on HEV Genotype 3 ORF2 Capsid Protein Expressed in Nicotiana benthamiana
por: Mazalovska, Milena, et al.
Publicado: (2017) -
HEV-ORF3 Encoding Phosphoprotein Interacts With Hepsin
por: Wang, Chunyan, et al.
Publicado: (2014) -
Preparation and Immune Effect of HEV ORF2 P206@PLGA Nanoparticles
por: Yang, Yifei, et al.
Publicado: (2022)